Check out our new paper using EMA to show that specific cannabis modalities are associated with momentary changes in subjective drug effects, which have been previously linked to sustained and problematic use.
Thanks to co-authors @mayamatlack.bsky.social & @ebansell.bsky.social
We evaluated the translational pipeline, from preclinical & human lab models to RCTs for CUD, reviewing medication effects & discussing challenges in translating findings.
pubmed.ncbi.nlm.nih.gov/40760404/
Fun collaboration with @meghaney.bsky.social @cassiemoorephd.bsky.social @eliseweerts.bsky.social @carolinearout.bsky.social & Hannah Harris on pharmacotherapy for cannabis use disorder!
So well deserved. Congratulations @meghaney.bsky.social #CPDD2025
Excited to share our new paper in Drug and Alcohol Dependence highlighting the importance of the temporal proximity of cannabis and alcohol co-use on subjective drug effects and longitudinal risk.
@ebansell.bsky.social
www.sciencedirect.com/science/arti...
Has it been 18 days or 18 years.. I can no longer tell the difference
